Inventage Lab Inc.
Develops drug delivery systems using microfluidics for chronic diseases and gene therapies.
389470 | KO
Overview
Corporate Details
- ISIN(s):
- KR7389470006
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 중원구 둔촌대로388번길 24, 101호, 601호, 612호, 성남시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Inventage Lab Inc. is a clinical-stage biopharmaceutical company that develops advanced drug delivery systems (DDS) for chronic and intractable diseases. The company's core innovation is its proprietary Laminar-FLUIDigm™ platform, which utilizes microfluidics for the research and development of novel pharmaceuticals. Inventage Lab operates two primary technology platforms: IVL-DrugFluidic® for developing and manufacturing microsphere-based long-acting injectables, and IVL-GeneFluidic® for the formulation of Lipid Nanoparticles (LNPs) used in gene therapies. Its therapeutic pipeline focuses on unique-in-class treatments for conditions like Alzheimer's disease and androgenic alopecia, drug re-discovery for autoimmune disorders, and joint development of treatments for HIV and mRNA-based therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-21 00:00 |
Legal Proceedings Report
소송등의판결ㆍ결정 (신주상장금지 등 가처분-취하)
|
Korean | 5.3 KB | ||
| 2025-10-21 00:00 |
Legal Proceedings Report
소송등의판결ㆍ결정 (신주발행무효 확인의 소-취하)
|
Korean | 5.1 KB | ||
| 2025-10-20 00:00 |
Legal Proceedings Report
주요사항보고서(소송등의제기)
|
Korean | 6.7 KB | ||
| 2025-10-20 00:00 |
Legal Proceedings Report
주요사항보고서(소송등의제기)
|
Korean | 7.3 KB | ||
| 2025-09-23 00:00 |
Share Issue/Capital Change
전환청구권행사 (제2회차)
|
Korean | 8.6 KB | ||
| 2025-09-22 00:00 |
Share Issue/Capital Change
전환청구권행사 (제2회차)
|
Korean | 8.7 KB | ||
| 2025-09-10 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (알코올 의존성 및 opioid 의존성 치료제(IVL3004) 및 다발성 경화증 …
|
Korean | 15.3 KB | ||
| 2025-08-27 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.6 MB | ||
| 2025-08-08 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.4 KB | ||
| 2025-08-08 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.2 KB | ||
| 2025-07-31 00:00 |
M&A Activity
투자판단관련주요경영사항 (FGF-21기반 mRNA-LNP 대사성 질환치료제 독점적 권리 도입 계약 체결)
|
Korean | 10.9 KB | ||
| 2025-07-16 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 95.1 KB | ||
| 2025-07-16 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.2 KB | ||
| 2025-07-03 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 95.2 KB | ||
| 2025-07-03 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB |
Automate Your Workflow. Get a real-time feed of all Inventage Lab Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Inventage Lab Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inventage Lab Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
